Why consider treatment in China for Severe Asthma?

China offers advanced biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) and bronchial thermoplasty performed at JCI-accredited hospitals with experienced pulmonologists. Treatment costs in China are significantly lower than in Western countries, often 30-50% less, while maintaining high standards of care. Additionally, Chinese medical centers have access to the latest technologies and protocols, providing effective management for severe asthma.